Antineoplastic activities of MT81 and its structural analogue in Ehrlich ascites carcinoma-bearing swiss albino mice

Oxidative Medicine and Cellular Longevity

Volumn 3, Issue 1, 2010, Pages 61-70

  Choudhury, Sujata Maiti ^a   Gupta, Malaya ^b   Majumder, Upal Kanti ^b  

^a VIDYASAGAR UNIVERSITY   (India)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

Antitumor activity and antioxidant status; Ehrlich ascites carcinoma; Hematological parameters; Mean survival time; MT81 and its acetic acid derivative

Indexed keywords

ACETIC ACID DERIVATIVE; ACETIC ACID MT 81; ANTIOXIDANT; CATALASE; FLUOROURACIL; GLUTATHIONE; HEMOGLOBIN; MALONALDEHYDE; MT 81; MYCOTOXIN; PROTEIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CELL COUNT; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MEGADOSE; DRUG STRUCTURE; EHRLICH ASCITES TUMOR; ENZYME ACTIVITY; ERYTHROCYTE COUNT; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LEUKOCYTE COUNT; LIFESPAN; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PERITONEUM CELL; SURVIVAL TIME; TUMOR CELL; TUMOR VOLUME;

MUS;

EID: 77953441301     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.3.1.10495     Document Type: Article

References (63)

1. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001; 411:390-5.
2. Pankin DM, Bray F, Ferlay J, Pisani P. Global cancer statistico (2002) CA cancer. J Clin 2005; 55:74-108.
3. Williams RH, Lively DH, Delong DC, Cline JC, Sweeney MJ, Poore GA, Larsan SM. J Antibiot 1968; 21:463.
4. Phillips TD, Chan PK, Hayes AW. Biochem Pharmacol 1980; 29:19.
5. Essery JM, O' Herron FA, McGregor DN, Bradner WT. Preparation and antitumor activities of some derivatives of 5-methoxysterigmatocystin. J Med chem 1976; 19:1339-42.
6. Claridge CA, Schmitz H, Bradner WT. Antitumor activity of some microbial and chemical transformation products of anguidine (4, 15-diacetoxyscirpene-3-ol) . Cancer Chemotherapy Pharmacol 1979; 2:181-2.
7. Kameko T, Schmitz H, Essery JM, Rose W, Howell HG, O' Herron FA, et al. Struchural modification of anguidin and antitumor activities of its analognes. J Med Chem 1982; 25:579-89.
8. RAmu A, Yagen B, Ramu N. The cytotozicity of T-2 toxin and related 12, 13-epoxytrichothecenes to Adriamycin-Sensitive and -resistant P388 teukemia cells. Cancer Chemotherapy Pharmacol 1989; 24:264-7.
9. Bousquet PF, Panlsen LA, Fonday C, Lipski KM, Loncy KJ, Fon TP. Effect of cytochasim B in culture and in vivo on murine Madison 109 Luns carcinoma and on B16 melanoma. Cancer Res 1990; 50:1431-9.
10. Sigle-Murandi F, Steiman R, Krivobok S, Beriel H, Benoit-Guyod JL. Antitumor activity of patrtin and structural analogs. Pharmazie 1992; 47:288-91.
11. Ono M, Saknda S, Suzuki A, Isogai A., Aflastatin A, a novel irhibitor of aflatoxin production by aflatoxigenic fungi. J Antibiot (Tokyo) 1997; 50:111-8.
12. Alvi KA, Rabenstein J, Woodard J, Banker DD, Berghold JD, Lynch J, et al. 14'-Hydroxymytoxin B and 1 hydroxyroridin E, two new cytotoxic trichothecenes from Myrothecinm roridum. J Nat Prod 2002; 65:742-4.
13. Antony M, Shukla Y, Janardhanan KK. Protection effect of tenuazonic acid against dimethye benz (a) antracene-induced skin carcinogenesis in mice. Teratog carcinog Mutogen 2002; 22:309-14.
14. Han HC, Lindequist U, Hyun JW, Kim YH, An HS, Lee DH, Kim HW. Apoptosis induction by 4beta-acetoxyscirpendiol from paecilomyces tenuipes in human leukaemia cell lines. Pharmazie 2004; 59:42-9.
15. Vigushim DM, Mirsaidi N, Broke G, Sun C, Pace P, Imuan L, et al. Gliotoxin is a dual inhibitor of farnesyl and geranyltransferase I with antitumor activity against Breast cancer in vivo. Med Orcol 2004; 21:21-30.
16. Igarashi Y, Tabuta y, Sekine A, Fujii K, Harada K, Oikawa T, et al. directed biosynthesis of fluorinated pseurotim A, Synerazol and gliotoxin. J Antibiot 2004; 57:748-54.
17. Fimtani V, Richetti A. chemotherapy 1993; 39:59.
18. Jow C, Chou B, Chen J. Tsai Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome release, caspase 3 activation: the causative role of calcium. Cancer Letters 216:65-173.
19. Masahira N, Hsuy H, Hirota A, Shimas, Nakayama M. J Antibioties 1989; 42:218.
20. Veno Y, Veno I, Ito K, Tatsuno T. Experientia 1967; 23:1001.
21. Veno Y, Veno I, Sato N, Iitoi Y, Saito M, Enomoto M, Tsunoda H. Jap J Exp Med 1971; 41:177.
22. Chaudhary SC, Alam MS, Siddiqui MS, Athar M. Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis. Chem Biol Interact 2009; 179:145-53.
23. Ardelt B, Juan G, Burfeind P, Salomon T, Wu JM, Hsieh TC, et al. An anti-tumor ribonuclease suppresses intracellular oxidative stress. Int J Oncol 2007; 31:663-9.
24. Yin JJ, Lao F, Meng J, Fu PP, Zhao Y, Xing G, Gao X. Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger. Mol Pharmacol 2008; 74:1132-40.
25. Lee JH, Lee HJ, Lee HJ, Choi WC, Yoon SW, Ko SG. Rhus verniciflua Stokes prevents cisplatin-induced cytotoxicity and reactive oxygen species production in MDCK-I renal cells and intact mice. Phytomedicine 2009; 16:188-97.
26. Cebovi T, Spasi S, Popovi M. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo. Phytother Res 2008; 22:1097-103.
27. Gupta M, Chatterjee T, Sengupta S, Majumder SK. Structure of a new mycotoxin (MT81). Indian J Chem 1984; 13:393.
28. Gupta M, Dey SN, Dolui AK, Mukherjee S, Basu SK, Batabyal SK. Some enzymes and substrates of Embden-Meyerhof pathway of different tissues and related hormones of mycotoxin, MT81 treated mice. Indian J Exp Biol 1988; 26:315-22.
29. Choudhury S, Rana MP, Chatterjee TK, Mazumder UK, Gupta M. Antimicrobial activities of mycotoxin MT81 and its structural derivatives. Indian J Exp Biol 1992; 30:140.
30. Majumder UK, Gupta M, Chowdhury S, Saha A. Antileishmanial activities of mycotoxin MT81 and its derivatives. Indian J Exp Biol 1993; 31:888-90.
31. Chatterjee T. Haematological changes produced in mice by a new mycotoxin (MT81).III World Conference on Clinical Pharmacology and Therapeutics, Stockholm 1986.
32. Gupta M, Chatterjee T, Dey SN, Mazumder SK. Effect of a new mycotoxin (MT81) from Penicillium nigricans on liver function in mice. Indian Drugs 1982; 19:430.
33. Gupta M, Chatterjee T, Dattagupta S, Bagchi GK. Proceedings of the All India SympoSium on Mycotoxin. Bhagalpur University 1983; 103.
34. Gupta M, Chatterjee T. Indian J Pharmacol 1985; 17:195.
35. Maiti Choudhury S, Roy G, Gupta M, Majumder UK. The central nervous system depressant activities of Mycotoxin MT81 and its Acetylated and Benzoylated analogues. Al Ame en J Med Sci 2008; 1:104-14.
36. Gupta M, Majumdar UK, Ray MR, Mukhopadhayay DK. Inhibition of experimental murine tumors by MT81, a new mycotoxin from Penicillium nigricans. Neoplasma 1997; 44:329-33.
37. Clarkson BD, Burchenal JH. Preliminary seceening of antineoplasic drugs. Prog Clin Cancer 1965; 1:625-9.
38. Price VE, Greenfield RE. Anemia in cancer. Avd Cancer Res 1958; 5:199-200.
39. Hogland HC. Hemnatological complications of cancer chemotherapy. Semin Oncol 1982; 9:95-102.
40. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Radic Biol Med 1990; 8:583-99.
41. Cerutti PA. Pro-oxidant ststus and tumor promossion. Science 1985; 227:375-81.
42. Fenninger LD, Mider GB. Energy and nitrogen metabolism in cancer. Avd Cancer Res 1954; 2:229-53.
43. Meister A. Glutathione metabolism and its selective modification. J Biochem 1988; 263:17205-8.
44. Mates JM, Perez-Gomez C, Nunez de Castro I. Antioxidant enzymes and human disease. Clin Biochem 1999; 32:595-603.
45. Gupta A, Batts B, Kwei Ka, Dvorakova K, Stratton Sp, Briehl MM, et al. Attenuation of catalase activity in the malignant phenotype plays a functional role in an in vitro model for tumor progression. Cancer Lett 2001; 73:115-25.
46. Yagi K. Lipid perosxides and human diseases. Chem Phys Lipids 1987; 45:337-51.
47. Sinclair AJ, Barnett AH, Lunie J. Free radical and autooxidant systems in health and disease. Br J Hosp Med 1990; 43:334-44.
48. Sun Y, Oberly LW, Elwell JH, Sierra Rivera E. Antioxidant enzyme activityes in normal and transformaes mice liver cells. Int J Cancer 1989; 44:1028-33.
49. Marklund SL, Westman NG, Lundgren E, Roos G. Copper-and-zinc-containing superoxide dismutase, managanese-containinh superoxide dismutase, catalase and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res 1982; 42:1955-61.
50. Chaudhary SC, Alam MS, Siddiqui MS, Athar M. Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis. Chem Biol Interact 2009; 179:145-53.
51. Sheeja KR, Kuttan G, Kuttan R. Cytotoxic and antitumor activity of Berberin. Amala Res Bull 1997; 17:73-6.
52. Kavamani S, Manisenthil Kumar KT. Effect of methanal extract of Ericostemna littorate on Dalton's lymphoma. J Ethnopharmacol 2000; 71:349-52.
53. Mazumder UK, Gupta M, Maiti S, Mukherjee M. Atitumor activity of Hygroohilaspinasa on Ehrlich ascites carcinoma and sarcoma-180 induced mice. Indian J Expt Biol 1997; 35:473-7.
54. Gupta M, Mazumder Uk, Rath N, Mukhopadhyay DK. Antitumor activity of methanolic extract of Cassia fistula L. seed against Ehrlich ascites carcinoma. L Erthnopharmacol 2000; 72:151-6.
55. Sur P, Ganguly DK. Tea plant root extract (TRE) as an antineoplastic agent. Planta Med 1994; 60:106-9.
56. rd ed. Chicago: The University of Chicago Press 1965; 4-6.
57. th ed. Philadelphia 1961; 326.
58. nd ed. London. J and A Churchill 1985; 38-48.
59. Ohkawa H, Onishi N, Yagi K. Assay foir lipid perxidation in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979; 95:351-8.
60. Grifth Mindr P. Determination of glutathione and glutathione disulphide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1998; 106:207-12.
61. Marklund S, Marklund G. Involvement of superoxide anion radical in the auto oxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47:469-74.
62. rd ed. New York: Academic Press 1983; 273.
63. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein mesurment with the-phenol reagent. J Biol Chem 1951; 193:265-75.